Cited by 406Neuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

MHCII Is Required for -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration

Open access
Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J. +2 more·2013·Journal of Neuroscience

Abstract

Accumulation of α-synuclein (α-syn) in the brain is a core feature of Parkinson disease (PD) and leads to microglial activation, production of inflammatory cytokines and chemokines, T-cell infiltration, and neurodegeneration. Here, we have used both an in vivo mouse model induced by viral overexpression of α-syn as well as in vitro systems to study the role of the MHCII complex in α-syn-induced neuroinflammation and neurodegeneration. We find that in vivo, expression of full-length human α-syn causes striking induction of MHCII expression by microglia, while knock-out of MHCII prevents α-syn-induced microglial activation, antigen presentation, IgG deposition, and the degeneration of dopaminergic neurons. In vitro, treatment of microglia with aggregated α-syn leads to activation of antigen processing and presentation of antigen sufficient to drive CD4 T-cell proliferation and to trigger cytokine release. These results indicate a central role for microglial MHCII in the activation of both the innate and adaptive immune responses to α-syn in PD and suggest that the MHCII signaling complex may be a target of neuroprotective therapies for the disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.5610-12.2013

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MHC-II expression on activated microglia is associated with proinflammatory cytokine release of TNF-α, IL-1β, and CD80.

    “MHC-II expression on activated microglia has been shown to be associated with proinflammatory cytokine release of TNF-α, IL-1β, and CD80 [36, 37].”

    From Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice (2019) · cites this paper as [36]

    The section on α-synuclein-induced CD4 T-cell proliferation and cytokines (page unavailable) reports increased TNF and IL-1β production when treated microglia were cocultured with CD4 T cells. It does not report CD80 release, and microglia alone did not show a significant inflammatory response under the tested conditions. The claim therefore omits the T-cell interaction required for the reported cytokine response and adds an unsupported CD80 component. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • MHCII expression precedes and regulates dopaminergic neurodegeneration in the substantia nigra.

    “Furthermore, MHCII expression precedes and regulates dopaminergic neurodegeneration in the substantia nigra [94,95,96].”
  • Overexpression of α-syn can induce MHC-II expression by microglia.

    “In vivo and in vitro studies have demonstrated that overexpression of α-syn can induce the MHC-II expression by microglia.”
  • MHC-II expression in microglia can play an important role in innate and adaptive immune responses in PD.

    “The MHC-II expression in microglia cells can play an important role in the immune responses (innate and adaptive) in PD (Michelucci et al., 2009; Harms et al., 2013; Gonzalez et al., 2015).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 39 · Cited by 406

Authors
Harms, A. S., Cao, S., Rowse, A. L., Thome, A. D., Li, X., Mangieri, L. R., Cron, R. Q., Shacka, J. J., Raman, C., & Standaert, D. G.
Affiliations
University of Alabama at Birmingham (US)
Venue
Journal of Neuroscience
Published
2013-06-05
Volume
33
Issue
23
Pages
9592-9600
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2025810715
Cited by
406
References
39
Citations by year
2026: 24 · 2025: 27 · 2024: 58 · 2023: 36 · 2022: 42 · 2021: 43 · 2020: 32 · 2019: 27 · 2018: 33 · 2017: 23 · 2016: 19 · 2015: 20 · 2014: 21 · 2013: 1
FWCI
11.39
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Alabama
  • National Institutes of Health (P30 AR48311)
  • National Institute of Allergy and Infectious Diseases (R01AI076562)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007450, P30AR048311, P30 AR 48311)
  • National Center for Research Resources (G20RR022807, G20RR025858)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
MHC class II, alpha-synuclein, Parkinson's disease, microglial activation, dopaminergic neuron loss, CD4+ T cell proliferation, antigen presentation, neuroinflammation, IgG deposition, neuroprotection
MeSH terms
Animals, Animals, Newborn, Cells, Cultured, Genes, MHC Class II, Humans, Male, Mice, Inbred C57BL, Nerve Degeneration, Parkinson Disease, CD4-Positive T-Lymphocytes, Microglia, Mice, Knockout, Cell Proliferation, Mice, alpha-Synuclein, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review